Sanofi P/E Ratio
Sanofi (SANOFI) P/E ratio is 20.14 (Moderate), EPS (TTM) ₹179.46, current price ₹3223.40 on NSE vs historical average P/E of 30.32 (50.0th percentile) — High - Growth expectations or overvalued. Analyse SANOFI shareholding pattern to track promoter, FII and institutional holdings.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
SANOFI P/E Ratio — Valuation Signal & Historical Context
Sanofi P/E 20.14 vs historical average 30.32, range 20.0–40.64 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see SANOFI screener.
- Current PE is 33.6% below historical average
- Trading at discount to sector average PE of 49.2
Sanofi P/E Ratio Historical Trend
SANOFI annual price-to-earnings ratio — 2 years, EPS and year-end price. Current P/E 20.14 vs historical average 30.32. Browse SANOFI balance sheet details for revenue, profit, balance sheet and cash flow data.
SANOFI Historical P/E Ratio — EPS, Year-End Price & Valuation
Sanofi annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2024 | 40.64 | 179.45 | ₹7292.15 | NSE | High |
| 2023 | 20.0 | 261.89 | ₹5238.10 | NSE | Moderate |
SANOFI vs Healthcare Peers — P/E Ratio Comparison
Sanofi P/E 20.14 vs Healthcare average 49.2, median 29.34 — range 0.97–869.57.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.13 | ₹53 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.39 | ₹7,561 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.61 | ₹1,146 | Low |
| Amwill Health Care | AMWILL | 6.04 | ₹65 | Low |
| Mono Pharmacare | MONOPHARMA | 6.85 | ₹20 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹28 | Low |
| Brooks Laboratories | BROOKS | 7.38 | ₹166 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |